Reading, United Kingdom

Satish Kumar Iyemperumal

This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satish Kumar Iyemperumal. Retrieved from https://idiyas.com/inventor/satish-kumar-iyemperumal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Satish Kumar Iyemperumal

Introduction

Satish Kumar Iyemperumal is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cystic fibrosis. His work has led to advancements that could improve the lives of many patients suffering from this condition.

Latest Patents

Satish holds a patent for "Crystalline forms of CFTR modulators." This patent discloses crystalline forms of salts of Compound I. It also includes pharmaceutical compositions comprising these salts, methods of treating cystic fibrosis using the same, and methods for making these compositions.

Career Highlights

Satish is currently employed at Vertex Pharmaceuticals, Inc., a company known for its focus on developing transformative medicines for serious diseases. His role at Vertex has allowed him to work on groundbreaking research and development projects that aim to address unmet medical needs.

Collaborations

Some of his notable coworkers include Andrey Peresypkin and Yi Shi. Their collaborative efforts contribute to the innovative environment at Vertex Pharmaceuticals, fostering advancements in drug development.

Conclusion

Satish Kumar Iyemperumal's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of cystic fibrosis, highlight the importance of research and collaboration in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…